Surgery Cost Of Revenue from 2010 to 2024

SGRY Stock  USD 23.39  0.38  1.65%   
Surgery Partners Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 1.2 B in 2024. During the period from 2010 to 2024, Surgery Partners Cost Of Revenue regression line of annual values had r-squared of  0.84 and arithmetic mean of  976,885,384. View All Fundamentals
 
Cost Of Revenue  
First Reported
2013-12-31
Previous Quarter
582.9 M
Current Value
592.9 M
Quarterly Volatility
157 M
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Surgery Partners over the last few years. Cost of Revenue is found on Surgery Partners income statement and represents the costs associated with goods and services Surgery Partners provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Surgery Partners' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Surgery Cost Of Revenue Regression Statistics

Arithmetic Mean976,885,384
Geometric Mean668,357,608
Coefficient Of Variation71.01
Mean Deviation592,748,758
Median1,013,800,000
Standard Deviation693,701,185
Sample Variance481221.3T
Range1.9B
R-Value0.92
Mean Square Error80767.3T
R-Squared0.84
Slope142,517,212
Total Sum of Squares6737098.7T

Surgery Cost Of Revenue History

20241.2 B
20232.1 B
2022B
20211.7 B
20201.5 B
20191.4 B
20181.4 B

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue2.1 B1.2 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.